UCLA Hematology/Oncology - Santa Clarita is a clinical research site located in Valencia, California, United States 91355.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
UCLA Hematology/Oncology - Santa Clarita has participated in 8 clinical trials with 3 currently active.
Therapeutic areas: Advanced Solid Tumors, HER2-positive Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC).
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Valencia
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UCLA Hematology/Oncology - Santa Clarita has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCLA Hematology/Oncology - Santa Clarita has 8 clinical trials on record, with 3 currently active. Their work covers Advanced Solid Tumors, HER2-positive Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC).
UCLA Hematology/Oncology - Santa Clarita has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.